Followers | 246 |
Posts | 49771 |
Boards Moderated | 69 |
Alias Born | 08/29/2007 |
Sunday, October 01, 2023 3:17:13 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent OPT News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/14/2024 11:07:33 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/01/2024 11:04:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/11/2024 11:01:09 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/27/2023 11:01:07 AM
- Opthea to Receive US$35M Commitment and Additional US$50M Funding • GlobeNewswire Inc. • 12/27/2023 11:00:00 AM
- Opthea Receives A$8.8 million R&D Tax Incentive • GlobeNewswire Inc. • 12/19/2023 11:00:00 AM
- Opthea to Present at the FLORetina 2023 Congress • GlobeNewswire Inc. • 12/01/2023 10:30:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/09/2023 11:01:08 AM
- Opthea to Present at the Jefferies 2023 London Healthcare Conference • GlobeNewswire Inc. • 11/09/2023 10:30:00 AM
- Opthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) Conference • GlobeNewswire Inc. • 10/30/2023 09:30:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/27/2023 10:09:25 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/27/2023 10:06:19 AM
- Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFO • GlobeNewswire Inc. • 10/27/2023 09:30:00 AM
- Opthea to Participate at the 2023 Euretina Congress • GlobeNewswire Inc. • 10/02/2023 09:30:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/07/2023 10:04:12 AM
- Opthea to Present at the H.C. Wainwright 25th Annual Global Investment Conference • GlobeNewswire Inc. • 09/07/2023 09:30:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/28/2023 10:15:57 AM
- Opthea Successfully Completes Institutional Offer and Increases Capital Raising to A$90.0m (US$57.6 million¹) • GlobeNewswire Inc. • 08/28/2023 09:30:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/24/2023 10:16:02 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/01/2023 10:01:56 AM
- Opthea Announces “Sozinibercept” as the Nonproprietary Drug Name for OPT-302 • GlobeNewswire Inc. • 07/26/2023 10:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/24/2023 10:01:47 AM
- Opthea to Present at the 2023 Ophthalmology Innovation Summit • GlobeNewswire Inc. • 07/24/2023 10:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/13/2023 10:02:24 AM
- Opthea to Feature at the American Society of Retina Specialists 2023 Annual Meeting • GlobeNewswire Inc. • 07/13/2023 10:00:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM